DANIEL CLAUDIO DE OLIVEIRA GOMES

Title: Doctor
Research groups: CNPq (Google Translator version)
Curriculum: http://lattes.cnpq.br

Participation in projects:

Title	Starting date	Deadline (months)	Participation in the project
	09/05/2011	87	Coordinator *
	25/12/2012	24	Coordinator *
	03/06/2013	24	Coordinator *
	01/10/2016	24	Coordinator *
	22/05/2017	48	Coordinator *

Pages

Participants in examination boards:

Title	Name	Defense date	Course
In silico study of Human G-CSF Derivatives as Antibacterials	CHRISTINE FACCO SATURNINO	31/07/2013	M.Sc. in Biotechnology
Theoretical analysis of the antibacterial potential of peptides from the in silico cleavage of human erythropoietin	FLÁVIO MAURÍCIO PERINI	30/08/2013	M.Sc. in Biotechnology
Comparison Between the Intranasal and Intramuscular Routes for Immunization With a Staphylococcus Aureus Gross Antigen Vaccine	NATALY PESCINALLI STEGMILLER	30/04/2014	M.Sc. in Biotechnology
EVALUATION OF RESVERATROL THERAPEUTIC POTENTIAL LIKE A NEW DRUG AGAINST VISCERAL LEISHMANIOSIS	ESTEVÃO CARLOS SILVA BARCELOS	04/03/2016	M.Sc. in Biotechnology
Evaluation of the Role of the Tlr1 / 2 Agonist (pam3csk4) in Potentiating the Protective Effect of Laag Vaccine Administered Via Intranasal Against Visceral Murine Leishmaniasis.	EMMANOEL LOSS DIAS	05/09/2016	M.Sc. in Biotechnology

Pages

Disciplines taught:

Academic term	Code	Name	Hours	Course
2021/2	PBIO0023	Special Topics in Biotechnology I	30	Master's degree in biotechnology
2024/1	PBIO0026	Teaching Internship	30	Doctorate in biotechnology

Guided Students:

Name	Title	Defense date	Role	Type
NATALY PESCINALLI STEGMILLER	Comparison Between the Intranasal and Intramuscular Routes for Immunization With a Staphylococcus Aureus Gross Antigen Vaccine	30/04/2014	Advisor *	MSc dissertation
ESTEVÃO CARLOS SILVA BARCELOS	EVALUATION OF RESVERATROL THERAPEUTIC POTENTIAL LIKE A NEW DRUG AGAINST VISCERAL LEISHMANIOSIS	04/03/2016	Advisor *	MSc dissertation
EMMANOEL LOSS DIAS	Evaluation of the Role of the Tlr1 / 2 Agonist (pam3csk4) in Potentiating the Protective Effect of Laag Vaccine Administered Via Intranasal Against Visceral Murine Leishmaniasis.	05/09/2016	Advisor *	MSc dissertation
DIVAN HENRIQUE FERNANDES BARCELOS	EVALUATION OF Bacteriocin Leishmanicide Potential	21/03/2018	Advisor *	MSc dissertation
ANDRES FELIPE MENDEZ COREA	USE OF ADJUVANTS (CAF 09, CAF 01 AND MPL) MUCOSA-COMPATIBLE IN THE FORMULATION OF VACCINES AGAINST VICERAL LEISHMANIOSIS.	29/03/2018	Advisor *	MSc dissertation

Pages